TOXICITY OF TYROSINASE INHIBITORS (ITC) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML) AND PREVENTION MEASURES. EXPERIENCE OF THE CATALAN INSTITUTE OF ONCOLOGY (ICO)
Por:
Cirici, BX, Serrano, MS, Calduch, OG, Nunez, JL, Brunso, ML, Genovart, CB, Tenza, PV, Barreras, NE, Torras, SM, Montero, EO, Cat, JG and Plana, LZ
Publicada:
31 oct 2017
Categoría:
Hematology
Resumen:
Filiaciones:
:
ICO Badalona, Badalona, Spain
Serrano, MS:
ICO Girona, Girona, Spain
Calduch, OG:
ICO Badalona, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Brunso, ML:
ICO Girona, Girona, Spain
Genovart, CB:
ICO Duran & Reynals, Lhospitalet De Llobregat, Spain
Tenza, PV:
ICO Duran & Reynals, Lhospitalet De Llobregat, Spain
:
ICO Badalona, Badalona, Spain
Torras, SM:
ICO Badalona, Badalona, Spain
:
ICO Badalona, Badalona, Spain
:
ICO Badalona, Badalona, Spain
:
ICO Badalona, Badalona, Spain
|